NEW YORK STATE COMMON RETIREMENT FUND - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 85 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,000
-99.0%
489
-98.5%
0.00%
Q1 2022$97,000
-78.1%
32,513
-67.0%
0.00%
Q4 2021$442,000
-19.6%
98,413
-13.0%
0.00%
-100.0%
Q3 2021$550,000
-28.7%
113,171
+0.1%
0.00%0.0%
Q2 2021$771,000
-18.8%
113,079
-15.8%
0.00%0.0%
Q1 2021$949,000
+81.5%
134,374
+60.9%
0.00%0.0%
Q4 2020$523,000
+30.4%
83,524
+12.6%
0.00%
Q3 2020$401,000
+3.6%
74,1740.0%0.00%
Q2 2020$387,000
+65.4%
74,1740.0%0.00%
Q1 2020$234,000
-20.7%
74,174
+1.2%
0.00%
Q4 2019$295,000
+95.4%
73,324
+109.7%
0.00%
Q3 2019$151,000
+15.3%
34,974
+6.1%
0.00%
Q2 2019$131,000
-27.6%
32,954
-2.3%
0.00%
Q1 2019$181,000
+2.3%
33,724
-2.3%
0.00%
Q4 2018$177,000
-62.6%
34,524
-29.2%
0.00%
-100.0%
Q3 2018$473,000
-4.8%
48,7740.0%0.00%0.0%
Q2 2018$497,000
-19.6%
48,774
+2.7%
0.00%0.0%
Q1 2018$618,000
+14.4%
47,504
+57.4%
0.00%0.0%
Q4 2017$540,000
-28.8%
30,1830.0%0.00%0.0%
Q3 2017$758,000
-20.2%
30,183
-23.4%
0.00%0.0%
Q2 2017$950,000
+50.1%
39,399
+19.7%
0.00%0.0%
Q1 2017$633,000
+35.5%
32,908
+8.5%
0.00%0.0%
Q4 2016$467,000
+19.1%
30,322
+0.6%
0.00%0.0%
Q3 2016$392,000
+21.0%
30,148
+29.5%
0.00%
Q2 2016$324,000
+83.1%
23,285
+99.0%
0.00%
Q1 2016$177,000
-20.3%
11,7000.0%0.00%
Q4 2015$222,0000.0%11,7000.0%0.00%
Q3 2015$222,000
+25.4%
11,700
+70.2%
0.00%
Q2 2015$177,0006,8740.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders